logo

Oragenics Inc. (OGEN)



Trade OGEN now with
  Date
  Headline
1/14/2021 7:15:33 AM Oragenics Says Optimistic That Terra CoV-2 Vaccine Will Ultimately Prove To Have Several Advantages
1/7/2021 7:17:49 AM Oragenics Enters Into Material Transfer Agreement With Adjuvance Technologies For Use Of Adjuvant TQL1055
9/28/2020 8:06:00 AM Oragenics Provides An Update On Funding For Its SARS-CoV-2 Vaccine
8/20/2020 8:33:00 AM Oragenics And Avid Bioservices Enter Process Development And drug Substance Manufacturing Agreement
7/22/2020 7:38:03 AM Oragenics: Study Shows SARS-CoV-2 Spike Protein Licensed By Company From NIH Produces Neutralizing Antibodies
7/10/2020 7:38:28 AM Oragenics Continues Development Of TerraCoV2, Goal Of Bringing COVID-19 Vaccine Candidate Into Humantrials By Early 2021
5/4/2020 6:18:16 AM Oragenics Appoints Kim Murphy To Board
5/4/2020 6:03:40 AM Oragenics Acquires Noachis Terra Inc.
4/15/2020 6:35:35 AM Oragenics Reports Early Top-line Results Of Phase 2 Clinical Trial Of AG013
12/2/2019 8:38:06 AM Oragenics Completes Enrollment In Ongoing Phase 2 Trial Of Its Lead Product Candidate, AG013